Skip to main content

Advertisement

Log in

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y et al (2002) Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Ann Oncol 13:928–943 doi:10.1093/annonc/mdf155

    Article  PubMed  CAS  Google Scholar 

  2. Bermudez A, Marco F, Conde E, Mazo E, Recio M, Zubizarreta A (2000) Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica 85:894–895

    PubMed  CAS  Google Scholar 

  3. Sharma VR, Fleming DR, Slone S (2000) Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 96:1184–1186

    PubMed  CAS  Google Scholar 

  4. Suzan F, Ammor M, Ribrag V (2001) Fatal reactivation of cytomegalovirus infection after use of rituximab for a post transplantation lymphoproliferative disorder. N Engl J Med 345:1000 doi:10.1056/NEJM200109273451315

    Article  PubMed  CAS  Google Scholar 

  5. Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE et al (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99:1486–1488 doi:10.1182/blood.V99.4.1486

    Article  PubMed  CAS  Google Scholar 

  6. Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, Lobuglio AF, Jonas C, Kippenstein D, Dallire B, Varns C (1999) Treatment of patients with low grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268–276

    PubMed  CAS  Google Scholar 

  7. Westhoff TH, Jochimsen F, Schmittel A, Stoffler-Meilicke M, Schafer JH, Zidek W et al (2003) Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930 doi:10.1182/blood-2003-05-1403

    Article  PubMed  CAS  Google Scholar 

  8. Ng HJ, Lim LC (2001) Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. Ann Hematol 80:549–552 doi:10.1007/s002770100346

    Article  PubMed  CAS  Google Scholar 

  9. Dervite I, Hober D, Morel P (2001) Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 344:68–69 doi:10.1056/NEJM200101043440120

    Article  PubMed  CAS  Google Scholar 

  10. Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Hiroe K, Obara S et al (2004) Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin’s lymphoma. Ann Hematol 83:58–60 doi:10.1007/s00277-003-0748-4

    Article  PubMed  CAS  Google Scholar 

  11. Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M et al (2005) Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 4:599–608 doi:10.1517/14740338.4.3.599

    Article  PubMed  CAS  Google Scholar 

  12. Pereau G, Dris N, Estines O, Derancourt C, Levy S, Bernard P (2006) Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 155:1053–1056 doi:10.1111/j.1365-2133.2006.07451.x

    Article  Google Scholar 

  13. Yang SH, Kuo SH (2008) Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma. Ann Hematol 87:325–327 doi:10.1007/s00277-007-0396-1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yutaka Tsutsumi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsutsumi, Y., Shigematsu, A., Hashino, S. et al. Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido. Ann Hematol 88, 375–377 (2009). https://doi.org/10.1007/s00277-008-0585-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0585-6

Keywords

Navigation